Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_provenance.
- NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_assertion description "[Because solid tumors expressing ECGF-1 could also be lysed by the CTL, ECGF-1 is an interesting target for immunotherapy of both hematologic and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_provenance.
- NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_assertion evidence source_evidence_literature NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_provenance.
- NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_assertion SIO_000772 16497972 NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_provenance.
- NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_assertion wasDerivedFrom befree-20140225 NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_provenance.
- NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_assertion wasGeneratedBy ECO_0000203 NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_provenance.